Jun 7
|
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
|
Jun 7
|
Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO
|
Jun 7
|
AbbVie reports positive Phase II ovarian cancer trial data
|
May 16
|
AbbVie CEO latest heavy hitter to buy in Boca Raton
|
May 15
|
NeuroSense taps PhaseV’s ML tech for Phase III ALS trial analysis
|
May 14
|
AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal
|
May 14
|
3 Magnificent Stocks That Are Passive Income Machines
|
May 13
|
12 Undervalued Stocks That Just Raised Their Dividends
|
May 13
|
What Is the Dividend Payout for AbbVie Stock?
|
May 13
|
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders
|
May 11
|
29 Huge Companies That You’ve Never Heard of Before and Their Stock Prices
|
May 11
|
Earn $1000 Every Month From These 3 Stocks
|
May 11
|
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
|
May 10
|
Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
|
May 10
|
3 Rock-Solid Dividend Stocks That Are Ideal for Retirees
|
May 9
|
Q1 2024 Regenxbio Inc Earnings Call
|
May 8
|
QULIPTA™ (atogepant) Now Approved by Health Canada for the Preventive Treatment of Chronic Migraine in Adults
|
May 7
|
Teva Earnings Are Soon. What Could Keep the Stock Gains Going.
|
May 7
|
15 Best S&P 500 Dividend Stocks To Buy Now
|
May 7
|
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
|